| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Integrins | 56 | 2019 | 845 | 4.920 |
Why?
|
| Antigens, CD | 53 | 2015 | 4024 | 4.590 |
Why?
|
| Receptors, Very Late Antigen | 41 | 1997 | 74 | 2.570 |
Why?
|
| Membrane Glycoproteins | 30 | 2012 | 3769 | 2.140 |
Why?
|
| Cell Adhesion | 59 | 2011 | 3139 | 1.990 |
Why?
|
| Membrane Proteins | 37 | 2015 | 7873 | 1.940 |
Why?
|
| Acyltransferases | 4 | 2020 | 294 | 1.850 |
Why?
|
| Integrin alpha6beta4 | 9 | 2013 | 31 | 1.820 |
Why?
|
| Integrin alpha3beta1 | 16 | 2010 | 53 | 1.470 |
Why?
|
| Antigens, Surface | 33 | 2004 | 1663 | 1.320 |
Why?
|
| Cell Adhesion Molecules | 25 | 2010 | 1599 | 1.180 |
Why?
|
| Membrane Microdomains | 6 | 2008 | 202 | 1.010 |
Why?
|
| Palmitic Acid | 5 | 2008 | 154 | 0.940 |
Why?
|
| Receptors, Lymphocyte Homing | 7 | 1997 | 143 | 0.770 |
Why?
|
| Laminin | 10 | 2019 | 418 | 0.760 |
Why?
|
| Fibronectins | 21 | 2009 | 723 | 0.760 |
Why?
|
| Integrin alpha6 | 2 | 2012 | 30 | 0.750 |
Why?
|
| Lipoylation | 2 | 2012 | 64 | 0.730 |
Why?
|
| Tumor Cells, Cultured | 31 | 2012 | 6313 | 0.720 |
Why?
|
| Platelet Membrane Glycoproteins | 7 | 2000 | 293 | 0.660 |
Why?
|
| Protein Binding | 24 | 2011 | 9387 | 0.600 |
Why?
|
| Immunoglobulins | 5 | 2009 | 880 | 0.600 |
Why?
|
| Integrin alpha6beta1 | 5 | 2003 | 18 | 0.600 |
Why?
|
| Amino Acid Sequence | 42 | 2007 | 13814 | 0.590 |
Why?
|
| Cell Line | 57 | 2008 | 15994 | 0.580 |
Why?
|
| Avian Proteins | 3 | 2004 | 80 | 0.570 |
Why?
|
| Cytoplasm | 12 | 2008 | 1539 | 0.540 |
Why?
|
| Antibodies, Monoclonal | 53 | 2010 | 9274 | 0.530 |
Why?
|
| Antigens, Neoplasm | 5 | 2004 | 1983 | 0.520 |
Why?
|
| Integrin alpha4beta1 | 9 | 2003 | 121 | 0.510 |
Why?
|
| Molecular Sequence Data | 39 | 2007 | 18112 | 0.510 |
Why?
|
| Enzyme Stability | 2 | 2012 | 210 | 0.500 |
Why?
|
| Cysteine | 5 | 2007 | 873 | 0.490 |
Why?
|
| Cell Movement | 15 | 2015 | 5212 | 0.470 |
Why?
|
| Caveolins | 2 | 2004 | 104 | 0.470 |
Why?
|
| Kangai-1 Protein | 3 | 2011 | 25 | 0.470 |
Why?
|
| Macromolecular Substances | 19 | 2004 | 1456 | 0.470 |
Why?
|
| Cricetinae | 17 | 2001 | 2471 | 0.450 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2013 | 2940 | 0.450 |
Why?
|
| Cell Line, Tumor | 16 | 2020 | 16665 | 0.450 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 16 | 1997 | 707 | 0.440 |
Why?
|
| Antioxidants | 1 | 2020 | 1659 | 0.430 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2004 | 141 | 0.430 |
Why?
|
| Collagen | 14 | 2002 | 2684 | 0.410 |
Why?
|
| Receptors, Immunologic | 15 | 1991 | 1423 | 0.410 |
Why?
|
| Precipitin Tests | 14 | 2002 | 829 | 0.410 |
Why?
|
| Extracellular Matrix | 12 | 2011 | 1740 | 0.410 |
Why?
|
| Protein Structure, Tertiary | 10 | 2011 | 3847 | 0.410 |
Why?
|
| Blood Proteins | 3 | 2004 | 1122 | 0.410 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 3 | 2000 | 59 | 0.400 |
Why?
|
| ADAM Proteins | 2 | 2011 | 242 | 0.390 |
Why?
|
| Recombinant Fusion Proteins | 17 | 2004 | 3770 | 0.390 |
Why?
|
| Animals | 95 | 2017 | 168561 | 0.390 |
Why?
|
| Antigens, Differentiation | 8 | 1989 | 926 | 0.380 |
Why?
|
| Cell Proliferation | 7 | 2017 | 10472 | 0.380 |
Why?
|
| Apoptosis | 5 | 2020 | 9715 | 0.380 |
Why?
|
| beta Catenin | 2 | 2013 | 1058 | 0.370 |
Why?
|
| Manganese | 7 | 1998 | 408 | 0.370 |
Why?
|
| Neoplasm Metastasis | 5 | 2014 | 4839 | 0.360 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2010 | 182 | 0.350 |
Why?
|
| CHO Cells | 13 | 2001 | 1407 | 0.340 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2009 | 61 | 0.340 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2011 | 584 | 0.330 |
Why?
|
| Signal Transduction | 17 | 2015 | 23387 | 0.330 |
Why?
|
| Protein Conformation | 19 | 2005 | 4013 | 0.330 |
Why?
|
| RNA Interference | 6 | 2020 | 2890 | 0.320 |
Why?
|
| T-Lymphocytes | 24 | 2003 | 10163 | 0.320 |
Why?
|
| Transfection | 21 | 2002 | 5892 | 0.310 |
Why?
|
| Breast Neoplasms | 7 | 2020 | 20774 | 0.310 |
Why?
|
| Ligands | 14 | 2003 | 3293 | 0.310 |
Why?
|
| Epitopes | 18 | 2002 | 2569 | 0.300 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2013 | 4029 | 0.300 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 2006 | 0.290 |
Why?
|
| Camptothecin | 2 | 2020 | 572 | 0.280 |
Why?
|
| Oxidative Stress | 1 | 2017 | 3081 | 0.280 |
Why?
|
| Cross-Linking Reagents | 6 | 2007 | 694 | 0.270 |
Why?
|
| Cations, Divalent | 6 | 1998 | 166 | 0.270 |
Why?
|
| Mice, SCID | 3 | 2017 | 2715 | 0.270 |
Why?
|
| Adhesins, Bacterial | 2 | 1998 | 119 | 0.270 |
Why?
|
| Palmitates | 2 | 2004 | 74 | 0.260 |
Why?
|
| Humans | 146 | 2020 | 742088 | 0.260 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2011 | 1723 | 0.260 |
Why?
|
| Mice | 46 | 2017 | 81045 | 0.250 |
Why?
|
| Mice, Nude | 7 | 2017 | 3689 | 0.250 |
Why?
|
| Palmitic Acids | 1 | 2004 | 54 | 0.240 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2012 | 2505 | 0.240 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 7 | 1980 | 329 | 0.240 |
Why?
|
| Protein Interaction Mapping | 2 | 2007 | 627 | 0.240 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 1097 | 0.240 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2017 | 138 | 0.240 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5163 | 0.240 |
Why?
|
| Neoplasms | 5 | 2019 | 21596 | 0.240 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2009 | 472 | 0.240 |
Why?
|
| Receptor, erbB-2 | 2 | 2012 | 2410 | 0.230 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2009 | 1121 | 0.230 |
Why?
|
| Receptors, Cell Surface | 7 | 2003 | 2867 | 0.230 |
Why?
|
| Neoplasm Proteins | 6 | 2006 | 3691 | 0.230 |
Why?
|
| Cell Membrane Structures | 1 | 2003 | 27 | 0.220 |
Why?
|
| Skin Neoplasms | 2 | 2013 | 5662 | 0.220 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 13655 | 0.220 |
Why?
|
| Blotting, Western | 8 | 2012 | 5180 | 0.220 |
Why?
|
| Cell Membrane | 9 | 2006 | 3744 | 0.220 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2009 | 1989 | 0.220 |
Why?
|
| Cytoskeleton | 3 | 2006 | 1185 | 0.210 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 2842 | 0.210 |
Why?
|
| Base Sequence | 15 | 2008 | 12797 | 0.210 |
Why?
|
| Lymphocyte Activation | 16 | 1991 | 5519 | 0.210 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 6 | 2001 | 906 | 0.200 |
Why?
|
| Enterovirus B, Human | 4 | 1994 | 52 | 0.200 |
Why?
|
| Kidney Diseases | 1 | 2013 | 2145 | 0.200 |
Why?
|
| Molecular Weight | 18 | 1996 | 2255 | 0.200 |
Why?
|
| HEK293 Cells | 3 | 2017 | 4200 | 0.200 |
Why?
|
| Receptors, Fibronectin | 9 | 1996 | 39 | 0.200 |
Why?
|
| Neovascularization, Pathologic | 2 | 2014 | 2633 | 0.190 |
Why?
|
| Neoplasm Transplantation | 4 | 2015 | 2085 | 0.190 |
Why?
|
| Cell Aggregation | 5 | 1993 | 244 | 0.190 |
Why?
|
| Integrin alpha4 | 7 | 1997 | 92 | 0.190 |
Why?
|
| Cell Size | 2 | 2002 | 643 | 0.190 |
Why?
|
| Sequence Deletion | 7 | 2002 | 1526 | 0.180 |
Why?
|
| Cloning, Molecular | 9 | 2005 | 4322 | 0.180 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2001 | 315 | 0.180 |
Why?
|
| Plant Oils | 1 | 2000 | 202 | 0.180 |
Why?
|
| Extracellular Matrix Proteins | 3 | 1993 | 849 | 0.170 |
Why?
|
| Phosphorylation | 7 | 2012 | 8436 | 0.170 |
Why?
|
| Protein Kinase C | 2 | 2001 | 1227 | 0.170 |
Why?
|
| Receptors, Collagen | 7 | 1995 | 26 | 0.170 |
Why?
|
| Flow Cytometry | 17 | 2012 | 5975 | 0.170 |
Why?
|
| Receptors, Virus | 4 | 1999 | 648 | 0.170 |
Why?
|
| Integrin alpha Chains | 3 | 2012 | 97 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 4 | 2015 | 3612 | 0.160 |
Why?
|
| Dimerization | 3 | 2005 | 893 | 0.160 |
Why?
|
| Neurites | 1 | 2000 | 380 | 0.160 |
Why?
|
| K562 Cells | 3 | 2011 | 632 | 0.160 |
Why?
|
| Enzyme Activation | 5 | 2010 | 3701 | 0.160 |
Why?
|
| Rhabdomyosarcoma | 4 | 1996 | 382 | 0.150 |
Why?
|
| Prostaglandins | 4 | 1980 | 405 | 0.150 |
Why?
|
| Cells, Cultured | 12 | 2011 | 19223 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 3 | 2015 | 4465 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2001 | 578 | 0.150 |
Why?
|
| Mutagenesis | 2 | 2001 | 1263 | 0.150 |
Why?
|
| 3T3 Cells | 4 | 2003 | 1101 | 0.150 |
Why?
|
| Leukocytes | 4 | 1995 | 2039 | 0.150 |
Why?
|
| Integrin alpha3 | 4 | 2001 | 26 | 0.150 |
Why?
|
| Magnesium | 3 | 1995 | 813 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2005 | 2837 | 0.150 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2217 | 0.150 |
Why?
|
| Carrier Proteins | 3 | 1999 | 5019 | 0.140 |
Why?
|
| Protein Structure, Quaternary | 2 | 2011 | 437 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 2 | 1999 | 1363 | 0.140 |
Why?
|
| Melanoma | 1 | 2015 | 5462 | 0.140 |
Why?
|
| Neoplasms, Experimental | 1 | 2001 | 1274 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 2 | 2012 | 1655 | 0.140 |
Why?
|
| Structure-Activity Relationship | 7 | 1997 | 3133 | 0.130 |
Why?
|
| Tetradecanoylphorbol Acetate | 5 | 1995 | 821 | 0.130 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1998 | 675 | 0.130 |
Why?
|
| Peptide Fragments | 7 | 2002 | 5095 | 0.130 |
Why?
|
| Recombinant Proteins | 8 | 1998 | 6608 | 0.130 |
Why?
|
| Transplantation, Heterologous | 3 | 2015 | 2382 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2000 | 1801 | 0.130 |
Why?
|
| Receptors, Laminin | 5 | 1995 | 26 | 0.130 |
Why?
|
| Proteins | 4 | 2008 | 6096 | 0.130 |
Why?
|
| Dioxoles | 1 | 2015 | 104 | 0.120 |
Why?
|
| Octoxynol | 3 | 2002 | 77 | 0.120 |
Why?
|
| Kinetics | 10 | 1996 | 6474 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 437 | 0.120 |
Why?
|
| Multigene Family | 3 | 2000 | 1102 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 3504 | 0.120 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1996 | 433 | 0.120 |
Why?
|
| Proteomics | 1 | 2007 | 3618 | 0.120 |
Why?
|
| Transendothelial and Transepithelial Migration | 2 | 2012 | 102 | 0.120 |
Why?
|
| Cell Line, Transformed | 3 | 2012 | 898 | 0.120 |
Why?
|
| Muscle, Skeletal | 2 | 1999 | 4933 | 0.120 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2015 | 200 | 0.120 |
Why?
|
| Receptors, Peptide | 2 | 1996 | 272 | 0.120 |
Why?
|
| Integrin beta Chains | 1 | 1994 | 121 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1996 | 4553 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2001 | 2915 | 0.120 |
Why?
|
| Binding Sites | 7 | 2003 | 6115 | 0.120 |
Why?
|
| Enzyme Induction | 2 | 2004 | 475 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2009 | 3456 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2015 | 314 | 0.110 |
Why?
|
| Mice, Knockout | 5 | 2012 | 14554 | 0.110 |
Why?
|
| Receptors, IgG | 1 | 1997 | 582 | 0.110 |
Why?
|
| Frizzled Receptors | 1 | 2013 | 91 | 0.110 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2012 | 62 | 0.110 |
Why?
|
| Serine Endopeptidases | 3 | 1988 | 1073 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2012 | 11 | 0.110 |
Why?
|
| Peroxides | 4 | 1980 | 74 | 0.110 |
Why?
|
| Leukemia, Erythroblastic, Acute | 3 | 1998 | 189 | 0.110 |
Why?
|
| Fibroblasts | 6 | 2012 | 4143 | 0.110 |
Why?
|
| Chromatography, Liquid | 2 | 2007 | 977 | 0.110 |
Why?
|
| Mutation | 11 | 2011 | 29717 | 0.110 |
Why?
|
| Caveolin 1 | 2 | 2004 | 264 | 0.110 |
Why?
|
| Hematopoietic Stem Cells | 8 | 1996 | 3381 | 0.100 |
Why?
|
| Transcellular Cell Migration | 1 | 2011 | 2 | 0.100 |
Why?
|
| Receptors, Antigen | 2 | 1989 | 53 | 0.100 |
Why?
|
| Fibrosarcoma | 3 | 2001 | 348 | 0.100 |
Why?
|
| Cell Differentiation | 6 | 2002 | 11470 | 0.100 |
Why?
|
| Models, Biological | 6 | 2008 | 9581 | 0.100 |
Why?
|
| U937 Cells | 1 | 2011 | 268 | 0.100 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2011 | 114 | 0.090 |
Why?
|
| Amino Acid Motifs | 2 | 2005 | 936 | 0.090 |
Why?
|
| Glycoproteins | 3 | 1993 | 2260 | 0.090 |
Why?
|
| Carcinogens | 1 | 2012 | 466 | 0.090 |
Why?
|
| HeLa Cells | 4 | 2009 | 3127 | 0.090 |
Why?
|
| Gene Expression Regulation | 4 | 2013 | 12071 | 0.090 |
Why?
|
| Conserved Sequence | 2 | 2005 | 1202 | 0.090 |
Why?
|
| Peptides | 5 | 1998 | 4392 | 0.090 |
Why?
|
| Calcium | 4 | 1995 | 5753 | 0.090 |
Why?
|
| Glycosylation | 2 | 2004 | 1123 | 0.090 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2012 | 520 | 0.090 |
Why?
|
| Seminal Vesicles | 3 | 1978 | 101 | 0.090 |
Why?
|
| Solubility | 3 | 1998 | 1083 | 0.090 |
Why?
|
| Epidermal Growth Factor | 2 | 2012 | 709 | 0.090 |
Why?
|
| Extracellular Space | 2 | 2002 | 594 | 0.090 |
Why?
|
| Wnt Proteins | 1 | 2013 | 721 | 0.090 |
Why?
|
| Benzamides | 1 | 2015 | 1378 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 1799 | 0.080 |
Why?
|
| Integrin beta4 | 2 | 2001 | 31 | 0.080 |
Why?
|
| Wnt1 Protein | 1 | 2008 | 118 | 0.080 |
Why?
|
| Disulfides | 2 | 2005 | 457 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1999 | 2906 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1995 | 1504 | 0.080 |
Why?
|
| Bacterial Proteins | 3 | 1998 | 3843 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 874 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 547 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 21821 | 0.080 |
Why?
|
| Hematopoietic System | 1 | 1988 | 108 | 0.080 |
Why?
|
| Pulmonary Fibrosis | 1 | 2012 | 526 | 0.080 |
Why?
|
| Transgenes | 1 | 2011 | 1009 | 0.080 |
Why?
|
| Oligopeptides | 4 | 1995 | 1176 | 0.080 |
Why?
|
| Melanoma, Experimental | 1 | 2011 | 559 | 0.080 |
Why?
|
| Antigens | 2 | 1984 | 1462 | 0.080 |
Why?
|
| Jurkat Cells | 2 | 2001 | 742 | 0.070 |
Why?
|
| Models, Molecular | 3 | 2005 | 5454 | 0.070 |
Why?
|
| Random Allocation | 1 | 2012 | 2425 | 0.070 |
Why?
|
| Blotting, Northern | 5 | 1992 | 1581 | 0.070 |
Why?
|
| Quinazolines | 2 | 2012 | 1355 | 0.070 |
Why?
|
| Mass Spectrometry | 2 | 2007 | 2203 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2013 | 1538 | 0.070 |
Why?
|
| Mammary Glands, Human | 1 | 2008 | 200 | 0.070 |
Why?
|
| Cell Communication | 2 | 2008 | 1619 | 0.070 |
Why?
|
| B-Lymphocytes | 4 | 1992 | 4664 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2019 | 13029 | 0.070 |
Why?
|
| Stromal Cells | 1 | 2012 | 1353 | 0.070 |
Why?
|
| Integrin alpha2 | 2 | 1997 | 40 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2002 | 1683 | 0.070 |
Why?
|
| Endothelial Cells | 2 | 2011 | 3455 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2011 | 971 | 0.070 |
Why?
|
| Cricetulus | 2 | 2001 | 817 | 0.070 |
Why?
|
| Phytohemagglutinins | 4 | 1987 | 170 | 0.070 |
Why?
|
| Neutrophils | 1 | 1998 | 3711 | 0.070 |
Why?
|
| Ethylmaleimide | 1 | 2005 | 76 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2010 | 1791 | 0.070 |
Why?
|
| Mixed Function Oxygenases | 2 | 1977 | 272 | 0.070 |
Why?
|
| Immunoprecipitation | 2 | 2005 | 905 | 0.070 |
Why?
|
| Binding, Competitive | 4 | 1991 | 1159 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 1991 | 2524 | 0.070 |
Why?
|
| Genes | 1 | 1989 | 1892 | 0.070 |
Why?
|
| Actins | 2 | 2006 | 2120 | 0.060 |
Why?
|
| Tissue Distribution | 3 | 2008 | 2335 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 5 | 1987 | 573 | 0.060 |
Why?
|
| Amino Sugars | 1 | 2004 | 40 | 0.060 |
Why?
|
| Cell Division | 6 | 1999 | 4564 | 0.060 |
Why?
|
| Binding Sites, Antibody | 4 | 1995 | 349 | 0.060 |
Why?
|
| Molecular Conformation | 2 | 2005 | 563 | 0.060 |
Why?
|
| Stress, Mechanical | 2 | 2003 | 1684 | 0.060 |
Why?
|
| Integrin beta3 | 1 | 2004 | 122 | 0.060 |
Why?
|
| Synovial Fluid | 1 | 1986 | 394 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 1998 | 1675 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2002 | 2257 | 0.060 |
Why?
|
| DNA | 9 | 1993 | 7289 | 0.060 |
Why?
|
| Receptors, Growth Factor | 1 | 2004 | 334 | 0.060 |
Why?
|
| Phenylalanine | 1 | 2005 | 365 | 0.060 |
Why?
|
| Leucine | 1 | 2005 | 560 | 0.060 |
Why?
|
| Leukemia, T-Cell | 1 | 2003 | 104 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2011 | 3001 | 0.060 |
Why?
|
| Blood Platelets | 5 | 1988 | 2506 | 0.060 |
Why?
|
| Immunosorbent Techniques | 3 | 1988 | 184 | 0.060 |
Why?
|
| DNA, Recombinant | 1 | 2003 | 475 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2004 | 140 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 503 | 0.060 |
Why?
|
| Lysosomes | 1 | 2008 | 893 | 0.060 |
Why?
|
| Protein Transport | 1 | 2009 | 1988 | 0.060 |
Why?
|
| Interleukin-2 | 3 | 1985 | 1887 | 0.050 |
Why?
|
| Prostatic Neoplasms | 2 | 2020 | 11039 | 0.050 |
Why?
|
| Thymus Gland | 4 | 1995 | 1264 | 0.050 |
Why?
|
| Viral Envelope Proteins | 1 | 2006 | 635 | 0.050 |
Why?
|
| Prostaglandins G | 2 | 1979 | 2 | 0.050 |
Why?
|
| Mycoplasma Infections | 1 | 1982 | 118 | 0.050 |
Why?
|
| Gene Expression | 3 | 2012 | 7790 | 0.050 |
Why?
|
| Mycoplasma | 1 | 1982 | 139 | 0.050 |
Why?
|
| Brefeldin A | 1 | 2002 | 72 | 0.050 |
Why?
|
| Gels | 2 | 1995 | 427 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2009 | 8425 | 0.050 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2001 | 46 | 0.050 |
Why?
|
| Golgi Apparatus | 1 | 2004 | 410 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 192 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2004 | 551 | 0.050 |
Why?
|
| Isoelectric Focusing | 4 | 1988 | 181 | 0.050 |
Why?
|
| Glycine | 1 | 2005 | 671 | 0.050 |
Why?
|
| Fertilization | 1 | 2003 | 195 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2001 | 313 | 0.050 |
Why?
|
| DNA Primers | 2 | 2008 | 2892 | 0.050 |
Why?
|
| COS Cells | 2 | 2001 | 1160 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2004 | 391 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2005 | 4187 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2005 | 608 | 0.050 |
Why?
|
| Endopeptidases | 3 | 1994 | 772 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2005 | 686 | 0.050 |
Why?
|
| Benzophenanthridines | 1 | 2001 | 27 | 0.050 |
Why?
|
| Microscopy, Video | 1 | 2002 | 245 | 0.050 |
Why?
|
| Phenanthridines | 1 | 2001 | 51 | 0.050 |
Why?
|
| Goats | 1 | 2001 | 172 | 0.050 |
Why?
|
| Astrocytes | 1 | 2009 | 1266 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 462 | 0.050 |
Why?
|
| Exocytosis | 1 | 2003 | 353 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 960 | 0.050 |
Why?
|
| Membrane Fusion | 1 | 2003 | 273 | 0.050 |
Why?
|
| Genistein | 1 | 2001 | 84 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2723 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 3557 | 0.050 |
Why?
|
| Calibration | 1 | 2003 | 815 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2012 | 3465 | 0.050 |
Why?
|
| Disease Progression | 2 | 2008 | 13256 | 0.050 |
Why?
|
| DNA, Complementary | 3 | 1999 | 2049 | 0.050 |
Why?
|
| Rats | 4 | 1998 | 24265 | 0.050 |
Why?
|
| Magnetics | 1 | 2003 | 609 | 0.050 |
Why?
|
| Staurosporine | 1 | 2001 | 251 | 0.040 |
Why?
|
| Alkaloids | 1 | 2001 | 190 | 0.040 |
Why?
|
| Polyethylene Glycols | 2 | 2000 | 1181 | 0.040 |
Why?
|
| Growth Cones | 1 | 2000 | 117 | 0.040 |
Why?
|
| Female | 12 | 2020 | 379592 | 0.040 |
Why?
|
| Dystroglycans | 1 | 1999 | 60 | 0.040 |
Why?
|
| Desmin | 1 | 1999 | 130 | 0.040 |
Why?
|
| Prostaglandin Endoperoxides | 1 | 1978 | 12 | 0.040 |
Why?
|
| Large Neutral Amino Acid-Transporter 1 | 1 | 1998 | 10 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2001 | 2749 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11001 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 242 | 0.040 |
Why?
|
| Giant Cells | 1 | 1999 | 187 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2006 | 1372 | 0.040 |
Why?
|
| Yersinia | 1 | 1998 | 10 | 0.040 |
Why?
|
| Titrimetry | 1 | 1998 | 36 | 0.040 |
Why?
|
| Cell Fusion | 1 | 1999 | 297 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 853 | 0.040 |
Why?
|
| Molecular Structure | 2 | 1996 | 1907 | 0.040 |
Why?
|
| Plasmids | 2 | 2002 | 2305 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 491 | 0.040 |
Why?
|
| Peptide Mapping | 2 | 1989 | 263 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2002 | 834 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1990 | 1086 | 0.040 |
Why?
|
| Schwann Cells | 1 | 1999 | 195 | 0.040 |
Why?
|
| EF Hand Motifs | 1 | 1997 | 14 | 0.040 |
Why?
|
| Sodium Azide | 1 | 1997 | 24 | 0.040 |
Why?
|
| Histocompatibility Antigens | 1 | 1999 | 471 | 0.040 |
Why?
|
| Time Factors | 6 | 2003 | 40054 | 0.040 |
Why?
|
| Morphogenesis | 1 | 2002 | 752 | 0.040 |
Why?
|
| Dystrophin | 1 | 1999 | 285 | 0.040 |
Why?
|
| Epitope Mapping | 2 | 1995 | 311 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2004 | 1119 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2004 | 1051 | 0.040 |
Why?
|
| Cytochalasin B | 1 | 1997 | 74 | 0.040 |
Why?
|
| Biological Transport | 1 | 2002 | 2119 | 0.040 |
Why?
|
| Receptor Aggregation | 1 | 1997 | 80 | 0.040 |
Why?
|
| Leukemia, Experimental | 2 | 1996 | 246 | 0.040 |
Why?
|
| Trypsin | 2 | 1988 | 509 | 0.040 |
Why?
|
| Heme | 4 | 1980 | 307 | 0.040 |
Why?
|
| Serine | 1 | 2001 | 828 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 1999 | 397 | 0.040 |
Why?
|
| Temperature | 1 | 2003 | 2207 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 1982 | 1469 | 0.040 |
Why?
|
| Edetic Acid | 1 | 1997 | 277 | 0.040 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 1996 | 48 | 0.040 |
Why?
|
| Chelating Agents | 1 | 1998 | 380 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2000 | 1802 | 0.040 |
Why?
|
| Chemical Precipitation | 4 | 1984 | 180 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2004 | 1221 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2002 | 1961 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 2088 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2006 | 1582 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 1990 | 1820 | 0.030 |
Why?
|
| Interphase | 2 | 1988 | 224 | 0.030 |
Why?
|
| Mammals | 1 | 2001 | 1135 | 0.030 |
Why?
|
| Antibody Specificity | 3 | 1995 | 1094 | 0.030 |
Why?
|
| Integrin alpha5 | 1 | 1995 | 21 | 0.030 |
Why?
|
| Endothelium, Vascular | 4 | 1995 | 4455 | 0.030 |
Why?
|
| Phylogeny | 1 | 2003 | 2797 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1996 | 421 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1996 | 441 | 0.030 |
Why?
|
| Cell Polarity | 1 | 1998 | 644 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 1995 | 365 | 0.030 |
Why?
|
| Lung | 3 | 2012 | 9826 | 0.030 |
Why?
|
| Digitonin | 1 | 1994 | 27 | 0.030 |
Why?
|
| Kidney | 2 | 2005 | 7167 | 0.030 |
Why?
|
| Ionomycin | 1 | 1994 | 109 | 0.030 |
Why?
|
| Homeostasis | 2 | 2012 | 3335 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 1995 | 290 | 0.030 |
Why?
|
| Egtazic Acid | 1 | 1994 | 173 | 0.030 |
Why?
|
| Chromatography, Affinity | 2 | 1991 | 549 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 29010 | 0.030 |
Why?
|
| Hematopoiesis | 2 | 1995 | 2066 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 4801 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 1998 | 742 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2002 | 2751 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1996 | 655 | 0.030 |
Why?
|
| Vitronectin | 1 | 1993 | 44 | 0.030 |
Why?
|
| Calpain | 1 | 1994 | 150 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 5522 | 0.030 |
Why?
|
| Antibodies | 4 | 2004 | 2459 | 0.030 |
Why?
|
| Chickens | 1 | 1995 | 865 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1983 | 363 | 0.030 |
Why?
|
| Point Mutation | 1 | 1998 | 1624 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 708 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1997 | 1792 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 902 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2001 | 1416 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 1980 | 371 | 0.030 |
Why?
|
| Butadienes | 1 | 2012 | 110 | 0.030 |
Why?
|
| Male | 11 | 2020 | 349538 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1993 | 2552 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2012 | 120 | 0.030 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 13019 | 0.030 |
Why?
|
| Inflammation | 1 | 2012 | 10578 | 0.030 |
Why?
|
| Acute-Phase Reaction | 1 | 2012 | 91 | 0.030 |
Why?
|
| Chemotaxis | 1 | 1995 | 607 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2012 | 156 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2001 | 2938 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1992 | 203 | 0.030 |
Why?
|
| Cholesterol | 1 | 2000 | 2895 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 2012 | 142 | 0.030 |
Why?
|
| Self Tolerance | 1 | 2012 | 124 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 2455 | 0.020 |
Why?
|
| Peyer's Patches | 1 | 1991 | 121 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 1992 | 377 | 0.020 |
Why?
|
| Cell Survival | 2 | 1994 | 5872 | 0.020 |
Why?
|
| Bleomycin | 1 | 2012 | 499 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 878 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 6 | 1992 | 6382 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1986 | 3695 | 0.020 |
Why?
|
| Drosophila | 1 | 1998 | 1484 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 2012 | 277 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1992 | 682 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 1995 | 2014 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 1996 | 1144 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2012 | 553 | 0.020 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 2 | 1989 | 22 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 11363 | 0.020 |
Why?
|
| Receptors, Transferrin | 2 | 1992 | 296 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3800 | 0.020 |
Why?
|
| Pericytes | 1 | 2012 | 291 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1989 | 76 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 1994 | 1081 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1989 | 218 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 560 | 0.020 |
Why?
|
| Glutathione Peroxidase | 2 | 1980 | 255 | 0.020 |
Why?
|
| Clone Cells | 5 | 1984 | 1692 | 0.020 |
Why?
|
| Arachidonic Acids | 2 | 1980 | 299 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 9639 | 0.020 |
Why?
|
| Organ Specificity | 2 | 1991 | 2003 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1998 | 3420 | 0.020 |
Why?
|
| Placenta | 2 | 1988 | 1694 | 0.020 |
Why?
|
| Cholic Acids | 1 | 1987 | 40 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1993 | 689 | 0.020 |
Why?
|
| Blood | 2 | 1988 | 598 | 0.020 |
Why?
|
| Lipids | 1 | 1979 | 3302 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1989 | 517 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 1991 | 969 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1993 | 1118 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 1284 | 0.020 |
Why?
|
| Nitriles | 1 | 2012 | 952 | 0.020 |
Why?
|
| Epithelium | 2 | 1989 | 1680 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1994 | 2699 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 1999 | 3678 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 6171 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 1997 | 4554 | 0.020 |
Why?
|
| Chemistry | 2 | 1983 | 352 | 0.020 |
Why?
|
| Sheep | 2 | 1980 | 1437 | 0.020 |
Why?
|
| Phenols | 2 | 1980 | 501 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2006 | 12164 | 0.020 |
Why?
|
| Chemical Phenomena | 2 | 1983 | 517 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2012 | 1284 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1989 | 627 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1993 | 1899 | 0.020 |
Why?
|
| Glycoside Hydrolases | 1 | 1985 | 135 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1993 | 2126 | 0.020 |
Why?
|
| Deltaretrovirus | 1 | 1985 | 170 | 0.020 |
Why?
|
| Artifacts | 1 | 1994 | 1903 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1994 | 2440 | 0.020 |
Why?
|
| Algorithms | 1 | 2005 | 13853 | 0.020 |
Why?
|
| Rabbits | 3 | 1987 | 4886 | 0.020 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 1978 | 546 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 1992 | 2513 | 0.020 |
Why?
|
| Glomerular Mesangium | 1 | 1984 | 108 | 0.020 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2004 | 33 | 0.020 |
Why?
|
| Phorbol Esters | 1 | 2004 | 111 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2006 | 475 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1985 | 391 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3920 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 10943 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1994 | 2896 | 0.010 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1982 | 56 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1992 | 4211 | 0.010 |
Why?
|
| Isoantigens | 1 | 1985 | 567 | 0.010 |
Why?
|
| Tunicamycin | 1 | 1982 | 112 | 0.010 |
Why?
|
| Sarcoidosis | 1 | 1988 | 503 | 0.010 |
Why?
|
| Sialic Acids | 1 | 1982 | 127 | 0.010 |
Why?
|
| Encephalitis | 1 | 1985 | 423 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 26343 | 0.010 |
Why?
|
| Cattle | 2 | 1994 | 3923 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1983 | 1368 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2006 | 876 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1982 | 249 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1982 | 264 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1987 | 1692 | 0.010 |
Why?
|
| Sodium Cyanide | 1 | 1980 | 8 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 1982 | 353 | 0.010 |
Why?
|
| Naphthols | 1 | 1980 | 45 | 0.010 |
Why?
|
| Neurons | 1 | 2000 | 9325 | 0.010 |
Why?
|
| Lymphocyte Cooperation | 1 | 1980 | 112 | 0.010 |
Why?
|
| Apoproteins | 1 | 1980 | 44 | 0.010 |
Why?
|
| Free Radicals | 1 | 1980 | 236 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1980 | 237 | 0.010 |
Why?
|
| Catalase | 1 | 1980 | 222 | 0.010 |
Why?
|
| HLA Antigens | 2 | 1982 | 1382 | 0.010 |
Why?
|
| Skin | 1 | 1993 | 4353 | 0.010 |
Why?
|
| Prostaglandins H | 1 | 1978 | 23 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3862 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1987 | 1225 | 0.010 |
Why?
|
| Antibody Formation | 2 | 1981 | 1402 | 0.010 |
Why?
|
| Catalysis | 1 | 1980 | 760 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1985 | 1317 | 0.010 |
Why?
|
| Iron | 2 | 1977 | 1773 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1983 | 1470 | 0.010 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 1977 | 62 | 0.010 |
Why?
|
| Carcinoma | 1 | 1989 | 2374 | 0.010 |
Why?
|
| Apoenzymes | 1 | 1976 | 16 | 0.010 |
Why?
|
| Carbon Monoxide | 1 | 1980 | 531 | 0.010 |
Why?
|
| DNA Replication | 1 | 1984 | 1397 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1989 | 2542 | 0.010 |
Why?
|
| Cytokines | 1 | 2012 | 7317 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 1982 | 1170 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1976 | 220 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1976 | 313 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1999 | 581 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1990 | 6540 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1987 | 2229 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1980 | 1355 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1979 | 2187 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 18006 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 1983 | 517 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1992 | 156 | 0.010 |
Why?
|
| Hybrid Cells | 2 | 1982 | 441 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1992 | 318 | 0.010 |
Why?
|
| Monocytes | 1 | 1981 | 2593 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1992 | 293 | 0.010 |
Why?
|
| Myeloma Proteins | 2 | 1981 | 70 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1985 | 3076 | 0.010 |
Why?
|
| Immune Sera | 2 | 1981 | 641 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 1992 | 657 | 0.010 |
Why?
|
| Pregnancy | 2 | 1990 | 29087 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1990 | 433 | 0.010 |
Why?
|
| Acetylglucosaminidase | 1 | 1989 | 70 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1989 | 341 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1987 | 80 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1374 | 0.000 |
Why?
|
| Pulmonary Alveoli | 1 | 1988 | 675 | 0.000 |
Why?
|
| Chromosome Mapping | 2 | 1984 | 4742 | 0.000 |
Why?
|
| Blood Cells | 1 | 1987 | 309 | 0.000 |
Why?
|
| Chromosomes, Human, 4-5 | 1 | 1984 | 28 | 0.000 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1984 | 80 | 0.000 |
Why?
|
| Karyotyping | 1 | 1984 | 1243 | 0.000 |
Why?
|
| Hybridomas | 1 | 1982 | 452 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1981 | 313 | 0.000 |
Why?
|
| HLA-DR Antigens | 1 | 1983 | 644 | 0.000 |
Why?
|
| Rosette Formation | 1 | 1980 | 153 | 0.000 |
Why?
|
| Histocompatibility Testing | 1 | 1982 | 742 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1982 | 841 | 0.000 |
Why?
|
| Cell Transformation, Viral | 1 | 1981 | 565 | 0.000 |
Why?
|
| Growth Substances | 1 | 1980 | 783 | 0.000 |
Why?
|
| Lipoxygenase | 1 | 1977 | 74 | 0.000 |
Why?
|
| Malondialdehyde | 1 | 1977 | 104 | 0.000 |
Why?
|
| Genetic Markers | 1 | 1984 | 2633 | 0.000 |
Why?
|
| Isoantibodies | 1 | 1980 | 680 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1981 | 1040 | 0.000 |
Why?
|
| Platelet Aggregation | 1 | 1977 | 800 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1981 | 2614 | 0.000 |
Why?
|
| Leukemia | 1 | 1981 | 1507 | 0.000 |
Why?
|
| Smoking | 1 | 1988 | 8969 | 0.000 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1981 | 2986 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1981 | 3497 | 0.000 |
Why?
|
| Aging | 1 | 1983 | 8626 | 0.000 |
Why?
|
| Infant | 1 | 1983 | 35070 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1983 | 40955 | 0.000 |
Why?
|
| Child | 1 | 1983 | 77478 | 0.000 |
Why?
|
| Adolescent | 1 | 1983 | 85649 | 0.000 |
Why?
|
| Middle Aged | 1 | 1983 | 213127 | 0.000 |
Why?
|
| Adult | 1 | 1983 | 213712 | 0.000 |
Why?
|